Showing 141 - 160 results of 15,016 for search '(( significant increase decrease ) OR ( significant ((step decrease) OR (we decrease)) ))', query time: 0.58s Refine Results
  1. 141
  2. 142
  3. 143

    S8 File - by Martha R. Smith (20410184)

    Published 2024
    Subjects:
  4. 144
  5. 145
  6. 146
  7. 147

    S9 File - by Martha R. Smith (20410184)

    Published 2024
    Subjects:
  8. 148

    S7 File - by Martha R. Smith (20410184)

    Published 2024
    Subjects:
  9. 149
  10. 150
  11. 151
  12. 152
  13. 153

    Ecological and Health Risk Mediated by Micro(nano)plastics Aging Process: Perspectives and Challenges by Kexiao Song (13003200)

    Published 2025
    “…Through combining meta-analysis and analytic hierarchy process (AHP) model, we demonstrated that, compared to virgin MNPs, aged MNPs would result in biomass decrease and oxidative stress increase on organisms and lead to total N/P decrease and greenhouse gas emissions increase on ecosystems while causing cell apoptosis, antioxidant system reaction, and inflammation in human health. …”
  14. 154

    Ecological and Health Risk Mediated by Micro(nano)plastics Aging Process: Perspectives and Challenges by Kexiao Song (13003200)

    Published 2025
    “…Through combining meta-analysis and analytic hierarchy process (AHP) model, we demonstrated that, compared to virgin MNPs, aged MNPs would result in biomass decrease and oxidative stress increase on organisms and lead to total N/P decrease and greenhouse gas emissions increase on ecosystems while causing cell apoptosis, antioxidant system reaction, and inflammation in human health. …”
  15. 155
  16. 156
  17. 157

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  18. 158

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  19. 159

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  20. 160

    S1 Data - by Miki Doi (15347878)

    Published 2024
    Subjects: